Clinical Trial Update: Evaluation of Pegfilgrastim for Stem Cell Mobilization in Children [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pegfilgrastim for stem cell mobilization in children with solid tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Pegfilgrastim (Neulasta) (pegfilgrastim)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Solid Malignancies | Phase 2 | Status: TERMINATED